Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3406]
News [7759]
Articles [63]
Editorials [9]
Conferences [207]
elearning [49]
Galeterone safe and effective against prostate cancer
Dr Bruce Montgomery - University of Washington, Seattle, USA
Galeterone safe and effective against prostate cancer ( Dr Bruce Montgomery - University of Washington, Seattle, USA )
13 Apr 2012
Selumetinib controlled recurrent low-grade serous ovarian cancer
Dr John Farley - Creighton University, Phoenix, Arizona, USA
Selumetinib controlled recurrent low-grade serous ovarian cancer ( Dr John Farley - Creighton University, Phoenix, Arizona, USA )
13 Apr 2012
Ibrutinib induces responses in aggressive lymphomas
Dr Louis Staudt - National Cancer Institute, Bethesda, Maryland, USA
Ibrutinib induces responses in aggressive lymphomas ( Dr Louis Staudt - National Cancer Institute, Bethesda, Maryland, USA )
13 Apr 2012
Biomarker identified in relation to pazopanib in refractory urothelial cancer
Dr Andrea Necchi - National Cancer Institute of Milan, Italy
Biomarker identified in relation to pazopanib in refractory urothelial cancer ( Dr Andrea Necchi - National Cancer Institute of Milan, Italy )
13 Apr 2012
Effects of vitamin D on prostate cancer
Prof Reinhold Vieth - University of Toronto, Ontario, Canada
Effects of vitamin D on prostate cancer ( Prof Reinhold Vieth - University of Toronto, Ontario, Canada )
13 Apr 2012
Mouse models of metastatic breast cancer
Prof Jos Jonkers - Netherlands Cancer Institute, Amsterdam
Mouse models of metastatic breast cancer ( Prof Jos Jonkers - Netherlands Cancer Institute, Amsterdam )
4 Apr 2012
Advanced breast cancer consensus and the latest on triple negative breast cancer
Prof Eric Winer - Dana-Farber Cancer Institute, Boston, USA
Advanced breast cancer consensus and the latest on triple negative breast cancer ( Prof Eric Winer - Dana-Farber Cancer Institute, Boston, USA )
4 Apr 2012
Anti-HER2 treatment in metastatic breast cancer: trastuzumab and beyond
Dr Evandro De Azambuja - Institut Jules Bordet, Brussels, Belgium
Anti-HER2 treatment in metastatic breast cancer: trastuzumab and beyond ( Dr Evandro De Azambuja - Institut Jules Bordet, Brussels, Belgium )
2 Apr 2012
FLIMS workshop and management of triple negative breast cancer
Dr Margaret Hutka - Royal Marsden Hospital, London, UK
FLIMS workshop and management of triple negative breast cancer ( Dr Margaret Hutka - Royal Marsden Hospital, London, UK )
30 Mar 2012
ECCO and cancer care in Europe
Prof Cornelis van de Velde - President of ECCO
ECCO and cancer care in Europe ( Prof Cornelis van de Velde - President of ECCO )
29 Mar 2012
Managing HER2 overexpression in breast cancer
Prof Michael Untch - Helios Clinic, Berlin, Germany
Managing HER2 overexpression in breast cancer ( Prof Michael Untch - Helios Clinic, Berlin, Germany )
29 Mar 2012
Debate on the success of breast cancer screening programmes
Prof Richard Peto - Clinical Trial Service Unit, Oxford University, UK
Debate on the success of breast cancer screening programmes ( Prof Richard Peto - Clinical Trial Service Unit, Oxford University, UK )
24 Mar 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation